Commentary - The ISCHEMIA trial.

[1]  Marco Valgimigli,et al.  2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. , 2019, European heart journal.

[2]  E. V. van Beek,et al.  Sex associations and computed tomography coronary angiography-guided management in patients with stable chest pain , 2019, European heart journal.

[3]  C. Berry,et al.  Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Function and CT Coronary Angiogram (CorCTCA) study , 2019, American heart journal.

[4]  Christopher J. Rush,et al.  Ischemia and No Obstructive Coronary Artery Disease , 2019, Circulation. Cardiovascular interventions.

[5]  Christopher J. Rush,et al.  1-Year Outcomes of Angina Management Guided by Invasive Coronary Function Testing (CorMicA) , 2019, JACC. Cardiovascular interventions.

[6]  S. Miyata,et al.  Coronary Functional Abnormalities in Patients With Angina and Nonobstructive Coronary Artery Disease. , 2019, Journal of the American College of Cardiology.

[7]  D. Mark,et al.  Predictive Model for High-Risk Coronary Artery Disease: Insights From the PROMISE Trial , 2019, Circulation. Cardiovascular imaging.

[8]  Christopher J. Rush,et al.  Stratified Medical Therapy Using Invasive Coronary Function Testing in Angina: The CorMicA Trial. , 2018, Journal of the American College of Cardiology.

[9]  Sean M. O'Brien,et al.  International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial: Rationale and design , 2018, American heart journal.

[10]  S. Thom,et al.  Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial , 2018, The Lancet.

[11]  Hiroaki Shimokawa,et al.  International standardization of diagnostic criteria for microvascular angina. , 2018, International journal of cardiology.

[12]  P. Libby,et al.  Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade , 2017, Circulation.

[13]  F. Crea,et al.  International standardization of diagnostic criteria for vasospastic angina , 2015, European heart journal.

[14]  Daniel Berman,et al.  Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease. , 2015, The New England journal of medicine.

[15]  Scot-Heart Investigators,et al.  CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial , 2015, The Lancet.

[16]  D. Berman,et al.  Optimal medical therapy with or without PCI for stable coronary disease. , 2007, The New England journal of medicine.

[17]  S. Reis,et al.  The Economic Burden of Angina in Women With Suspected Ischemic Heart Disease: Results From the National Institutes of Health–National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation , 2006, Circulation.